课题基金 / 基金详情

Development of multimodal gene therapy for gastrointestinal cancer using in vivo electroporation

Development of multimodal gene therapy for gastrointestinal cancer using in vivo electroporation
利用体内电穿孔开发胃肠癌多模式基因治疗
批准号:
14370377
负责人:
MATSUBARA Hisairo
金额:
$7.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
制备了一种新的细胞因子白细胞介素21和白细胞介素23的cDNA。证实了将这些新的细胞因子基因转导到肿瘤细胞中可以诱导强大的肿瘤免疫。并且,对于使用裸鼠的人食管癌移植模型,也确认了IL-21的抗肿瘤活性的效果。检测了由肿瘤特异性微型启动子启动的HSV-tk基因的效用。HSV-tk基因治疗最有趣的效应是旁观者效应,这是一种允许杀死未转导细胞的现象。利用中期因子的最小启动子区驱动HSV-tk基因,通过体内电穿孔将IL-21 DNA导入肿瘤细胞,这一联合策略产生了一种有效的基因治疗方法,并改进safety.in体内电穿孔法,但其应用范围有限,临床应用范围较窄。体内电穿孔抗癌药物的临床试验 ...更多信息 地毯直到现在被用于仅限于皮下肿瘤。因此,研制出了一种可在纤维内窥镜下使用的新型电极,在猪模型中,在开胸或剖腹手术下对食管或肝脏进行体内电穿孔不会产生生理效应,可以安全地进行。这些结果有助于临床应用。改进后的电极既可在纤维内窥镜下使用,也可在镜下操作。目前,正在申请专利。与基因转移相结合,希望能获得很高的基因表达量,通过组蛋白去乙酰基转移酶抑制剂(FK 226)可以增强转染基因的转录。FK 226诱导了一个肿瘤抑制基因,我们证实了在人食管癌细胞中显示出抗肿瘤活性的效果。分析细胞因子基因的抗肿瘤效果的增强作用和通过使用FK 226的体内电穿孔的组合对疫苗的效果。少
英文摘要
The preparation of cDNA of interleukin-21 and-23 which is a new cytokine gene was done. It could confirm that powerful tumor immunity was induced by transducing these new cytokine genes to the tumor cells. And, as for human esophageal cancer transplantation model as well which a nude mice was used for, the effect on an anti-tumor activity of IL-21 was confirmed. The utility of the HSV-tk gene which is promoted by tumor specific mini-promoter was examined. The most interesting effect of HSV-tk gene therapy is the by-stander effect, a phenomenon allowing the killing of untransduced cells. By using the minimal promoter region of midkine to drive HSV-tk gene, and in vivo electroporation to transduce the IL-21 DNA into the tumors, this comibination strategy produces an efficient gene therapy with improved safety.in vivo electroporatio under the view adds a limitation to that utility and clinical application range gets narrow. The clinical trials of in vivo electroporation using anticancer d … More rugs until now was used for is limited to the subcutaneous tumor. Therfore the new electrode which could be used under the fiberscope was developed, in vivo electroporation to the esophagus or the liver under thoracotomy or laparotomy in swine model didn't give it a physiological effect and it could be carried out safely. These results caused to clinical application. The electrode which could be used by fiberscope or under the scopic operation was improved. And that prototype was completed.At present, an application for a patent is being prepared.As for the combination with the gene transfer, a very high gene expression is expected so that histone deacethyl taransferase inhibitor (FK226) may strengthen the transcription of the transfected gene. One of the tumor suppressor genes was induced by FK226, and we confirmed that effect on an anti-tumor activity was shown in the human esophageal cancer cells. It will be analyzed about the reinforcement action of the effect on an anti-tumor of cytokine genes and the effect on vaccine by the combination of in vivo electroporation using FK226. Less
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Ugai S, Shimozato O, Yu L, Wang YQ, Kawamura K, Tagawa M., et al.: "Transduction of the IL-21 and IL-23 genes to human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects."Cancer Gene Ther.. 10・10. 771-778
Ugai S、Shimozato O、Yu L、Wang YQ、Kawamura K、Takawa M.等人:“将 IL-21 和 IL-23 基因转导至人胰腺癌细胞中,产生自然杀伤细胞依赖性和非依赖性的抗肿瘤作用效果。“癌症基因治疗..10・10.771-778
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation.
低电压电穿孔产生的抗血管生成因子基因对结肠26产生的协同抗肿瘤作用。
DOI: --
发表时间: 2004
期刊: Cancer Gene Ther 11(9)
影响因子: --
作者: [Uesato, M.]
通讯作者: M.
Miyazaki S, Gunji Y, Matsubara H, Shimada H, Uesato M, Suzuki T, Kouzu T, Ochiai T.: "Possible Involvement of Antitumor Immunity in the Eradication of Colon 26 Induced by Low-Voltage Electrochemotherapy with Bleomycin."Surg Today. 33・1. 39-44 (2003)
Miyazaki S、Gunji Y、Matsubara H、Shimada H、Uesato M、Suzuki T、Kouzu T、Ochiai T.:“抗肿瘤免疫可能参与博来霉素低压电化学疗法诱导的 26 号结肠根除”。今日外科。 33・1。39-44(2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1007/s005950300006
发表时间: 2003-01-01
期刊: SURGERY TODAY
影响因子: 2.5
作者: [Miyazaki, S, Gunji, Y, Ochiai, T]
通讯作者: Ochiai, T
共 12 条
    海外基金